Skip to main content
. 2016 Mar 11;16:41. doi: 10.1186/s12890-016-0203-7

Table 1.

Patient demographics and interventions

Chemotherapy No chemotherapy
No. of patients 43 (40 %) 61 (60 %)
Mean age (yrs) (SD) 64 (15) 68 (12)
Cancer primary
 Lung (Small cell) 0 (0 %) 1 (2 %)
 Lung (Non-small cell) 17 (40 %) 16 (26 %)
 Mesothelioma 3 (7 %) 9 (15 %)
 Breast 11 (26 %) 16 (26 %)
 Other 12 (28 %) 19 (31 %)
Median duration IPC in-situ (days) (IQR) 28 (14–58) 69 (47–143)
Median duration of concurrent chemotherapy (IQR) 52 (21–105) (~4 cycles) -